Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to geophysical exploration and biomedical sensing. Their performance critically ...

Promotions and a strategic hire position Tersus Solutions for its next phase of growth These leadership updates reflect ...

Abstract: In electric traction applications, researchers are employing pole phase modulation (PPM) based multiphase induction machines (MIM) to achieve a broader range of speed and torque, allowing ...

Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical tools, announced a research collaboration with Soin ...

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division. This was supported by lab experiments showing that lowering deuterium levels ...

Executives from Equillium (NASDAQ:EQ) outlined the scientific rationale and near-term development plans for its lead program, EQ504, during a recent fireside chat focused on immunology and ...

Abstract: The presence of adversarial examples can cause synthetic aperture radar (SAR) image classification systems to produce incorrect predictions, severely compromising their accuracy and ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion ...

Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.

New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...

Agency Feedback Provides Regulatory Clarity on Enrichment Strategy and Confirms CDR-SB as Sole Primary Endpoint for Registrational ...

NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data results from its Phase 2a ...